Safety and efficacy evaluation of long-course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer: Intermediate results of a multicenter, phase II study

被引:0
|
作者
Yang, Z. [1 ]
Gao, J. [1 ]
Zhang, X. [1 ]
Wu, G. [1 ]
Deng, W. [1 ]
Liu, Y. [1 ]
Zhang, J. [2 ]
Chen, G. [3 ]
Xu, R. [3 ]
Han, J. [4 ]
Li, A. [5 ]
Liu, G. [6 ]
Sun, Y. [7 ]
Kong, D. [8 ]
Bai, Z. [1 ]
Yao, H. [1 ]
Zhang, Z. [1 ]
机构
[1] Capital Med Univ, Beijing Friendship Hosp, Dept Gen Surg, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Friendship Hosp, Dept Pathol, Beijing, Peoples R China
[4] Capital Med Univ, Beijing Chaoyang Hosp, Dept Gen Surg, Beijing, Peoples R China
[5] Capital Med Univ, Xuanwu Hosp, Dept Gen Surg, Beijing, Peoples R China
[6] Tianjin Med Univ Gen Hosp, Dept Gen Surg, Tianjin, Peoples R China
[7] Tianjin Peoples Hosp, Dept Anorectal, Tianjin, Peoples R China
[8] TMUCIH, Dept Colorectal Canc, Tianjin, Peoples R China
关键词
D O I
10.1016/j.annonc.2022.10.079
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
47P
引用
收藏
页码:S1447 / S1447
页数:1
相关论文
共 50 条
  • [1] Safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer: Short-term results of a multicenter, phase II study.
    Yao, Hongwei
    Yang, Zhengyang
    Gao, Jiale
    Zhang, Xiao
    Wu, Guocong
    Wei, Deng
    Liu, Yishan
    Zhang, Jie
    Chen, Guangyong
    Xu, Rui
    Han, Jiagang
    Li, Ang
    Liu, Gang
    Sun, Yi
    Kong, Dalu
    Bai, Zhigang
    Zhang, Zhongtao
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15599 - E15599
  • [2] Rationale and design of a prospective, multicenter, phase II clinical trial of safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer (NCRT-PD1-LARC trial)
    Yang, Zhengyang
    Zhang, Xiao
    Zhang, Jie
    Gao, Jiale
    Bai, Zhigang
    Deng, Wei
    Chen, Guangyong
    An, Yongbo
    Liu, Yishan
    Wei, Qi
    Han, Jiagang
    Li, Ang
    Liu, Gang
    Sun, Yi
    Kong, Dalu
    Yao, Hongwei
    Zhang, Zhongtao
    BMC CANCER, 2022, 22 (01)
  • [3] Rationale and design of a prospective, multicenter, phase II clinical trial of safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer (NCRT-PD1-LARC trial)
    Zhengyang Yang
    Xiao Zhang
    Jie Zhang
    Jiale Gao
    Zhigang Bai
    Wei Deng
    Guangyong Chen
    Yongbo An
    Yishan Liu
    Qi Wei
    Jiagang Han
    Ang Li
    Gang Liu
    Yi Sun
    Dalu Kong
    Hongwei Yao
    Zhongtao Zhang
    BMC Cancer, 22
  • [4] Clinical outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision in locally advanced rectal cancer with mesorectal fascia involvement
    Ha Lee, Jeong
    Kim, Nalee
    Yu, Jeong Il
    Yoo, Gyu Sang
    Park, Hee Chul
    Lee, Woo-Yong
    Yun, Seong Hyeon
    Kim, Hee Cheol
    Cho, Yong Beom
    Huh, Jung Wook
    Park, Yoon Ah
    Shin, Jung Kyong
    Park, Joon Oh
    Kim, Seung Tae
    Park, Young Suk
    Lee, Jeeyun
    Kang, Won Ki
    RADIATION ONCOLOGY JOURNAL, 2024, 42 (02): : 130 - 138
  • [5] Phase II study of long-course chemoradiotherapy followed by consolidation chemotherapy as total neoadjuvant therapy in locally advanced rectal cancer in Japan: ENSEMBLE-2
    Kagawa, Yoshinori
    Ando, Koji
    Uemura, Mamoru
    Watanabe, Jun
    Oba, Koji
    Emi, Yasunori
    Matsuhashi, Nobuhisa
    Izawa, Naoki
    Muto, Osamu
    Kinjo, Tatsuya
    Takemasa, Ichiro
    Oki, Eiji
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2024, 8 (06): : 1067 - 1075
  • [6] Laparoscopic total mesorectal excision following long course chemoradiotherapy for locally advanced rectal cancer
    Motson, Roger W.
    Khan, J. S.
    Arulampalam, T. H. A.
    Austin, R. C. T.
    Lacey, N.
    Sizer, B.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2011, 25 (06): : 1753 - 1760
  • [7] Laparoscopic total mesorectal excision following long course chemoradiotherapy for locally advanced rectal cancer
    Roger W. Motson
    J. S. Khan
    T. H. A. Arulampalam
    R. C. T. Austin
    N. Lacey
    B. Sizer
    Surgical Endoscopy, 2011, 25
  • [8] Outcomes using induction chemotherapy followed by long-course chemoradiotherapy as total neoadjuvant therapy for locally advanced rectal cancer
    Gatfield, E.
    Hughes, J.
    Kumaran, M.
    Doherty, G.
    Daly, M.
    Stancliffe, M.
    Jephcott, C.
    Wilson, C.
    Smith, S.
    Jadon, R.
    ANNALS OF ONCOLOGY, 2022, 33 : S329 - S329
  • [9] Transanal total mesorectal excision for locally advanced rectal cancer following neoadjuvant chemoradiotherapy
    Matsuda, Takeru
    Yamashita, Kimihiro
    Hasegawa, Hiroshi
    Sawada, Ryuichiro
    Koterazawa, Yasufumi
    Harada, Hitoshi
    Urakawa, Naoki
    Goto, Hironobu
    Kanaji, Shingo
    Kakeji, Yoshihiro
    SURGERY TODAY, 2025,
  • [10] Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer
    Ryan, R
    Gibbons, D
    Hyland, JMP
    Treanor, D
    White, A
    Mulcahy, HE
    O'Donoghue, DP
    Moriarty, M
    Fennelly, D
    Sheahan, K
    HISTOPATHOLOGY, 2005, 47 (02) : 141 - 146